Understanding the Relationship between Sleep and Psychiatric Disorders

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Psychiatric Diseases".

Deadline for manuscript submissions: closed (25 July 2023) | Viewed by 4072

Special Issue Editors


E-Mail Website
Guest Editor
1. School of Psychology, University of Lincoln, Lincoln, UK
2. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Interests: sleep medicine; mental health; psychiatric difficulties; psychological wellbeing; insomnia; idiopathic hypersomnia; cognitive processes

E-Mail Website
Guest Editor
Department of Psychology, Northumbria University, Newcastle upon Tyne, UK
Interests: sleep; mental health; psychiatric difficulties; personality; psychological well-being; insomnia; idiopathic hypersomnia; cognitive processes

E-Mail Website
Guest Editor
School of Health in Social Sciences, University of Edinburgh, Edinburgh, UK
Interests: traumatic brain injury; neuropsychological rehabilitation; brain injury; sleep disorders; sleep disorders and sleep medicine; actigraphy; mental health; well-being; stroke; gender equality & gender balance

Special Issue Information

Dear Colleagues,

Healthy sleep is essential for the optimal performance of physical, cognitive, and emotional processes (Markov et al., 2006; Spiegel et al., 1999). Sleep serves to maintain several key functions including memory consolidation (Klinzing et al., 2019), emotion regulation (Walker and van der Helm, 2009), and restoration of the body and brain. (Xie et al., 2013). When these vital processes are disturbed, the consequences are not only detrimental to everyday health and well-being (Prendergast et al., 2015), they increase vulnerability to psychiatric difficulties (Freeman et al., 2020). With that in mind, most psychiatric populations report a sleep-related complaint of some form. Whilst poor sleep and insomnia symptoms are perhaps most prevalent (Benca et al., 1992), additional complaints involve excessive daytime sleepiness, hypersomnolence, circadian rhythm disruption, or a culmination of varying sleep complaints (Buysee, 2010). After decades of empirical research, it is well accepted that sleep disruption predicts the first onset of psychiatric conditions, whilst worsening the severity of those experiencing pre-existing symptoms (Freeman et al., 2020).

This Special Issue aims to provide a further understanding of the complex relationship between sleep and psychiatric disorders. Here, authors are invited to submit novel research and contextually relevant systematic reviews that address a broad range of topics related to disturbed and/or disordered sleep in relation to particular psychiatric disorders. We particularly welcome data from well-screened patient populations meeting the appropriate diagnostic criteria; behavioral and neuroscience studies employing objective methods of sleep assessment (e.g., polysomnography, actigraphy) and/or subjective data (e.g., validated questionnaires, sleep diary data) in nonclinical and clinical populations; studies of a prospective or experimental design; randomized controlled trials with a focus on treatment outcomes; consideration of subpopulations based on age, sex and/or student status; literature reviews of a systematic nature which address a novel topic related to the current context. Overall, this Special Issue aims to present advances in sleep research which may improve the treatment and management of psychiatric disorders. 

Dr. Umair Akram
Dr. Sarah Allen
Dr. Maria Gardani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sleep medicine
  • mental health
  • psychiatric difficulties
  • psychological wellbeing
  • insomnia
  • hypersomnia
  • circadian rhythm disruption
  • apneas
  • anxiety
  • depression
  • schizophrenia
  • post traumatic stress
  • substance use
  • psychosis
  • bipolar disorder
  • mania

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 467 KiB  
Article
Sleep Apnea and Substance Use Disorders Associated with Co-Occurrence of Anxiety Disorder and Depression among U.S. Adults: Findings from the NSDUH 2008–2014
by Chun Xu, Priscila Acevedo, Liang Wang, Nianyang Wang, Kaysie Ozuna, Saima Shafique, Annu Karithara, Victoria Padilla, Chunxiang Mao, Xin Xie and Kesheng Wang
Brain Sci. 2023, 13(4), 661; https://doi.org/10.3390/brainsci13040661 - 14 Apr 2023
Viewed by 1492
Abstract
Few studies have focused on sleep apnea and substance use disorders with co-occurrence of anxiety disorder and depression. This study included a total of 270,227 adults, 9268 with co-occurrence of anxiety disorder and depression in the past year, from the combined 2008–2014 National [...] Read more.
Few studies have focused on sleep apnea and substance use disorders with co-occurrence of anxiety disorder and depression. This study included a total of 270,227 adults, 9268 with co-occurrence of anxiety disorder and depression in the past year, from the combined 2008–2014 National Survey on Drug Use and Health (NSDUH) data, which are the latest datasets with measures of anxiety disorder and sleep apnea. Weighted multinomial logistic regression analyses were used to estimate the associations between anxiety disorder and depression and their co-occurrence. Comorbidity was highly prevalent: 40.4% of those with depression also met the criteria for anxiety disorder, whereas 51.8% of those with anxiety disorder also met the criteria for depression. The prevalences of anxiety only and co-occurrence increased from 2008 to 2014. The prevalences of anxiety disorder only, depression only, and co-occurrence of anxiety disorder and depression in individuals with sleep apnea were 4.4%, 12.9%, and 12.2%, respectively, and the prevalences in substance use disorders were 6.4%, 9.4%, and 10.7%, respectively. The results showed that sleep apnea, substance use disorders, and nicotine dependence were significantly associated with increased odds of anxiety disorder, depression, and co-occurrence (all p values < 0.0001). Furthermore, several chronic diseases (asthma, bronchitis, hypertension, and heart disease) were associated with the co-occurrence of anxiety disorder and depression. These findings suggest clinicians and other healthcare providers consider screening for depression and anxiety with sleep apnea and substance use disorders for improved therapeutic outcomes. Full article
Show Figures

Graphical abstract

10 pages, 281 KiB  
Article
Prevalence and Psychiatric Correlates of Illicit Substance Use in UK Undergraduate Students
by Holly Foster, Jodie Stevenson and Umair Akram
Brain Sci. 2023, 13(2), 360; https://doi.org/10.3390/brainsci13020360 - 19 Feb 2023
Cited by 2 | Viewed by 2077
Abstract
This study examined the prevalence of illegal drug use in UK students and motivators behind such behavior. Additionally, we explored possible relationships between substance use, psychosocial motivators, and psychiatric distress. A group (n = 543) of students completed online measures of substance [...] Read more.
This study examined the prevalence of illegal drug use in UK students and motivators behind such behavior. Additionally, we explored possible relationships between substance use, psychosocial motivators, and psychiatric distress. A group (n = 543) of students completed online measures of substance use, anxiety, depression, perceived stress, and insomnia. A series of reasons behind their use were ranked based on importance. Reported cannabis, cocaine, nitrous oxide, ketamine, and MDMA use were most prevalent based on lifetime, past year, and month assessments. The experience of anxiety, depression, perceived stress, and insomnia were related to increased reports of substance use. Poor self-confidence and self-medication were key motivators of illicit drug use in those presenting greater psychiatric distress. These outcomes add to the sparse body of literature concerning illicit substance use in relation to psychiatric distress amongst UK students. Furthermore, we provided novel insight into the psychosocial motivators of such use. Full article
Back to TopTop